"The problems with this are obvious," said Capizzi. These kinds of tests "treat human beings as things to be produced, sold or bought."
Although those behind test say they do not specifically seek to identify embryos that contain genes linked to higher intelligence, Genomic Prediction co-founder Stephen Hsu said that he believes there will be a demand for this service in the future.
"I think people are going to demand that. If we don't do it, some other company will," said Hsu in New Scientist.
Currently, something called a "polygenic risk score" can be calculated for adults. This score is calculated after an examination of a person's genes to identify increased risks for heart disease, dementia, or breast cancer. Until now, this has not been available for embryos.
Capizzi warned that a mentality of parents wanting a supposedly genetically perfect "designer" child will have dire effects on how people view others.
(Story continues below)
Subscribe to our daily newsletter
At Catholic News Agency, our team is committed to reporting the truth with courage, integrity, and fidelity to our faith. We provide news about the Church and the world, as seen through the teachings of the Catholic Church. When you subscribe to the CNA UPDATE, we'll send you a daily email with links to the news you need and, occasionally, breaking news.
As part of this free service you may receive occasional offers from us at EWTN News and EWTN. We won't rent or sell your information, and you can unsubscribe at any time.
"The logic of this leads to parents demanding refunds or exchanges of their children when they don't turn out as promised," Capizzi said.
"Not only, in other words, will the commodification of human beings in this way lead to throwing away unwanted embryos, it will lead to the abandonment of unwanted young people."